International Patent Roundtable Featuring Comparative Discussion of Product-by-Process Claim Strategy in the U.S. and Japan
26 June 2017
In the case of emerging technologies such as stem cells and nanotechnology, inventions are frequently claimed in product-by-process format when the exact physical differences of the end products are not yet known. Recent Supreme Court precedent in Japan has created turmoil for patent applicants seeking to pursue product-by-process claims, though they remain a well-accepted claiming format in the U.S.
Join us for an interactive roundtable discussion of comparative claim drafting strategies for protecting these types of inventions in the U.S. and Japan, as well as opportunities for enforcing, challenging, and defending these types of claims.
People
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.